CYH vs NRC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CYH exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a negative Price-to-Book ratio (-0.25), which indicates negative shareholders' equity. While the current P/E ratio appears deceptively low, the surge to a Forward P/E of 20.81 suggests a significant expected collapse in earnings. Revenue is contracting (-6.10% YoY) and the stock is in a persistent technical downtrend, losing 74% of its value over five years. The provided growth-based intrinsic value of $24.08 is fundamentally disconnected from the company's current balance sheet insolvency and should be disregarded.
NRC exhibits a severe disconnect between its current market price ($17.04) and its deterministic value markers, with a Graham Number of $2.64 and an Intrinsic Value of $3.50. While the Piotroski F-Score of 6/9 suggests stable operational health, this is overshadowed by critical solvency risks including a Debt/Equity ratio of 5.74 and a Current Ratio of 0.55. Fundamental growth is in sharp decline, with YoY earnings crashing by 74.40%, and the dividend is unsustainable with a payout ratio of 104%. The recent 1-year price surge appears speculative as it contradicts the bearish technical trend and deteriorating fundamentals.
Compare Another Pair
Related Comparisons
CYH vs NRC: Head-to-Head Comparison
This page compares Community Health Systems, Inc. (CYH) and National Research Corporation (NRC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.